Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novogen initiates phase I clinical trial with potential prostate cancer treatment

Feb. 9, 2000

Lorus Therapeutics receives US patent for antisense cancer therapies

Feb. 9, 2000

U.S. patent issued for B-cell lymphoma therapy

Feb. 9, 2000

Porphyrins designed at Schering for PDT and MRI

Feb. 9, 2000

Chinese investigators design novel antitumor agents

Feb. 8, 2000

Roche announces limitations on availability of FUDR

Feb. 8, 2000

Magainin begins phase II trial of squalamine in ovarian cancer

Feb. 8, 2000

Aptosyn/Xeloda combination to be tested in breast and colorectal cancers

Feb. 8, 2000

Peloruside A: a cytotoxic macrolide isolated from a marine sponge in New Zealand

Feb. 7, 2000

Cyclopentanones with antitumor and/or antiinflammatory activity synthesized at Shenyang university

Feb. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026